PDB Short entry for 2XTJ HEADER HYDROLASE/ANTIBODY 10-OCT-10 2XTJ TITLE THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 153-451; COMPND 5 SYNONYM: PCSK9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC-1, COMPND 6 PROPROTEIN CONVERTASE 9, PC9, SUBTILISIN/KEXIN-LIKE PROTEASE PC9; COMPND 7 EC: 3.4.21.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: LIGHT CHAIN CONSTANT DOMAIN, RESIDUES 108-213; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05; COMPND 21 CHAIN: D; COMPND 22 FRAGMENT: HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131; COMPND 23 ENGINEERED: YES; COMPND 24 MOL_ID: 5; COMPND 25 MOLECULE: FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05; COMPND 26 CHAIN: E; COMPND 27 FRAGMENT: HEAVY CHAIN CONSTANT DOMAIN, RESIDUES 132-233; COMPND 28 ENGINEERED: YES; COMPND 29 MOL_ID: 6; COMPND 30 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9; COMPND 31 CHAIN: P; COMPND 32 FRAGMENT: PRODOMAIN, RESIDUES 53-152; COMPND 33 SYNONYM: PCSK9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC-1, COMPND 34 PROPROTEIN CONVERTASE 9, PC9, SUBTILISIN/KEXIN-LIKE PROTEASE PC9; COMPND 35 EC: 3.4.21.-; COMPND 36 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETM-10; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PMORPHX9; SOURCE 18 OTHER_DETAILS: HUMAN COMBINATORIAL ANTIBODY PHAGE DISPLAY LIBRARY; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PMORPHX9; SOURCE 26 OTHER_DETAILS: HUMAN COMBINATORIAL ANTIBODY PHAGE DISPLAY LIBRARY; SOURCE 27 MOL_ID: 4; SOURCE 28 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 29 ORGANISM_COMMON: HUMAN; SOURCE 30 ORGANISM_TAXID: 9606; SOURCE 31 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 32 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 33 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 34 EXPRESSION_SYSTEM_PLASMID: PMORPHX9; SOURCE 35 OTHER_DETAILS: HUMAN COMBINATORIAL ANTIBODY PHAGE DISPLAY LIBRARY; SOURCE 36 MOL_ID: 5; SOURCE 37 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 38 ORGANISM_COMMON: HUMAN; SOURCE 39 ORGANISM_TAXID: 9606; SOURCE 40 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 41 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 42 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 43 EXPRESSION_SYSTEM_PLASMID: PMORPHX9; SOURCE 44 OTHER_DETAILS: HUMAN COMBINATORIAL ANTIBODY PHAGE DISPLAY LIBRARY; SOURCE 45 MOL_ID: 6; SOURCE 46 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 47 ORGANISM_COMMON: HUMAN; SOURCE 48 ORGANISM_TAXID: 9606; SOURCE 49 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 50 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 51 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 52 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 53 EXPRESSION_SYSTEM_PLASMID: PETM-10 KEYWDS HYDROLASE-ANTIBODY COMPLEX, SERINE PROTEASE, LDL-C, LDLR, EGF-A, KEYWDS 2 HYPERCHOLESTEROLEMIA EXPDTA X-RAY DIFFRACTION AUTHOR S.DI MARCO,C.VOLPARI,A.CARFI REVDAT 4 20-DEC-23 2XTJ 1 REMARK LINK REVDAT 3 08-MAY-19 2XTJ 1 REMARK REVDAT 2 22-DEC-10 2XTJ 1 JRNL REMARK REVDAT 1 03-NOV-10 2XTJ 0 JRNL AUTH Y.G.NI,S.DI MARCO,J.H.CONDRA,L.B.PETERSON,W.WANG,F.WANG, JRNL AUTH 2 S.PANDIT,H.A.HAMMOND,R.ROSA,R.T.CUMMINGS,D.D.WOOD,X.LIU, JRNL AUTH 3 M.J.BOTTOMLEY,X.SHEN,R.M.CUBBON,S.P.WANG,D.G.JOHNS, JRNL AUTH 4 C.VOLPARI,L.HAMURO,J.CHIN,L.HUANG,J.Z.ZHAO,S.VITELLI, JRNL AUTH 5 P.HAYTKO,D.WISNIEWSKI,L.J.MITNAUL,C.P.SPARROW,B.HUBBARD, JRNL AUTH 6 A.CARFI,A.SITLANI JRNL TITL A PCSK9-BINDING ANTIBODY THAT STRUCTURALLY MIMICS THE EGF(A) JRNL TITL 2 DOMAIN OF LDL-RECEPTOR REDUCES LDL CHOLESTEROL IN VIVO. JRNL REF J.LIPID RES. V. 52 78 2011 JRNL REFN ISSN 0022-2275 JRNL PMID 20959675 JRNL DOI 10.1194/JLR.M011445 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 30522 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1629 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2194 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.3200 REMARK 3 BIN FREE R VALUE SET COUNT : 136 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 199 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : -1.15000 REMARK 3 B33 (A**2) : 0.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.547 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.319 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.236 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.580 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.877 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6019 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8178 ; 1.413 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 780 ; 7.414 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 239 ;38.930 ;24.059 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 971 ;18.365 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;20.378 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 939 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4516 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2633 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4006 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 286 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.133 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.207 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.070 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3969 ; 0.581 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6253 ; 1.051 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2300 ; 1.323 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1924 ; 2.353 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THE FINAL MODEL CONTAINS RESIDUES 61-152 FROM THE REMARK 3 PCSK9 PRODOMAIN (CHAIN P) AND RESIDUES 155-157 AND 178-422 FROM REMARK 3 THE PCSK9 CATALYTIC DOMAIN (CHAIN A) THE FINAL MODEL CONTAINS REMARK 3 RESIDUES 1-212 FROM THE FAB LIGHT CHAIN (CHAINS B AND C)AND REMARK 3 RESIDUES 1-236 FROM THE FAB HEAVY CHAIN (CHAINS D AND E). THERE REMARK 3 WAS NO ELECTRON DENSITY PRESENT FOR PCSK9 RESIDUES 53-60, 153- REMARK 3 154, 158-177 AND 423-451, NOR FOR 1D05 FAB RESIDUES 237-255 OF REMARK 3 THE CONSTANT DOMAIN OF THE HEAVY CHAIN (CHAIN E) AND RESIDUE 213 REMARK 3 OF THE CONSTANT DOMAIN OF THE LIGHT CHAIN (CHAIN C). THESE REMARK 3 RESIDUES WERE THEREFORE EXCLUDED FROM THE REFINEMENT. ALL OVER REMARK 3 THE STRUCTURE, WHEN POOR DENSITY FOR SIDE CHAINS WAS PRESENT, REMARK 3 THE CORRESPONDING RESIDUE WAS MODELED AS ALA. ALL OVER THE REMARK 3 STRUCTURE, WHEN POOR DENSITY FOR SIDE CHAINS WAS PRESENT, THE REMARK 3 CORRESPONDING RESIDUE WAS MODELED AS ALA. REMARK 4 REMARK 4 2XTJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1290045730. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32238 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2W2M REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION EXPERIMENTS WERE REMARK 280 PERFORMED AT ROOM TEMPERATURE BY THE HANGING-DROP AND SITTING- REMARK 280 DROP METHODS. THIN PLATE-LIKE CRYSTALS WERE OBTAINED IN 100 MM REMARK 280 NA CITRATE PH 6.5, 13% PEG 6000. FOR DATA COLLECTION CRYSTALS REMARK 280 WERE TRANSFERRED TO A STABILIZING SOLUTION (20 MM TRIS PH 8.0, REMARK 280 50 MM NACITRATE PH 6.5, 100 MM NACL, 5% GLYCEROL, 1 MM TCEP, 1 REMARK 280 MICROM CACL2, 25% PEG6000), THEN TRANSFERRED FOR 2 MIN TO A REMARK 280 CRYOPROTECTANT SOLUTION (20 MM TRIS PH 8.0, 50 MM NACITRATE PH REMARK 280 6.5, 100 MM NACL, 20% GLYCEROL, 1 MM TCEP, 1 MICROM CACL2, 35% REMARK 280 PEG6000) AND FINALLY PLACED DIRECTLY INTO LIQUID NITROGEN., REMARK 280 VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.29450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 125.43000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.91700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 125.43000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.29450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.91700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 153 REMARK 465 ILE A 154 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 ARG A 160 REMARK 465 ILE A 161 REMARK 465 THR A 162 REMARK 465 PRO A 163 REMARK 465 PRO A 164 REMARK 465 ARG A 165 REMARK 465 TYR A 166 REMARK 465 ARG A 167 REMARK 465 ALA A 168 REMARK 465 ASP A 169 REMARK 465 GLU A 170 REMARK 465 TYR A 171 REMARK 465 GLN A 172 REMARK 465 PRO A 173 REMARK 465 PRO A 174 REMARK 465 ASP A 175 REMARK 465 GLY A 176 REMARK 465 GLY A 177 REMARK 465 GLY A 213 REMARK 465 THR A 214 REMARK 465 ARG A 215 REMARK 465 PHE A 216 REMARK 465 HIS A 217 REMARK 465 ARG A 218 REMARK 465 VAL A 423 REMARK 465 ILE A 424 REMARK 465 ASN A 425 REMARK 465 GLU A 426 REMARK 465 ALA A 427 REMARK 465 TRP A 428 REMARK 465 PHE A 429 REMARK 465 PRO A 430 REMARK 465 GLU A 431 REMARK 465 ASP A 432 REMARK 465 GLN A 433 REMARK 465 ARG A 434 REMARK 465 VAL A 435 REMARK 465 LEU A 436 REMARK 465 THR A 437 REMARK 465 PRO A 438 REMARK 465 ASN A 439 REMARK 465 LEU A 440 REMARK 465 VAL A 441 REMARK 465 ALA A 442 REMARK 465 ALA A 443 REMARK 465 LEU A 444 REMARK 465 PRO A 445 REMARK 465 PRO A 446 REMARK 465 SER A 447 REMARK 465 THR A 448 REMARK 465 HIS A 449 REMARK 465 GLY A 450 REMARK 465 ALA A 451 REMARK 465 ALA A 452 REMARK 465 GLY A 453 REMARK 465 THR A 454 REMARK 465 ALA A 455 REMARK 465 ALA A 456 REMARK 465 ALA A 457 REMARK 465 SER A 458 REMARK 465 HIS A 459 REMARK 465 HIS A 460 REMARK 465 HIS A 461 REMARK 465 HIS A 462 REMARK 465 HIS A 463 REMARK 465 HIS A 464 REMARK 465 ALA C 213 REMARK 465 GLN E 237 REMARK 465 LYS E 238 REMARK 465 LEU E 239 REMARK 465 ILE E 240 REMARK 465 SER E 241 REMARK 465 GLU E 242 REMARK 465 GLU E 243 REMARK 465 ASP E 244 REMARK 465 LEU E 245 REMARK 465 ASN E 246 REMARK 465 GLY E 247 REMARK 465 ALA E 248 REMARK 465 PRO E 249 REMARK 465 HIS E 250 REMARK 465 HIS E 251 REMARK 465 HIS E 252 REMARK 465 HIS E 253 REMARK 465 HIS E 254 REMARK 465 HIS E 255 REMARK 465 MET P 39 REMARK 465 LYS P 40 REMARK 465 GLY P 41 REMARK 465 SER P 42 REMARK 465 LYS P 43 REMARK 465 GLY P 44 REMARK 465 SER P 45 REMARK 465 LYS P 46 REMARK 465 GLY P 47 REMARK 465 SER P 48 REMARK 465 LYS P 49 REMARK 465 PRO P 50 REMARK 465 MET P 51 REMARK 465 SER P 52 REMARK 465 ALA P 53 REMARK 465 GLU P 54 REMARK 465 ALA P 55 REMARK 465 PRO P 56 REMARK 465 GLU P 57 REMARK 465 HIS P 58 REMARK 465 GLY P 59 REMARK 465 THR P 60 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 212 CG OD1 OD2 REMARK 470 GLN A 278 CG CD OE1 NE2 REMARK 470 LYS C 168 CG CD CE NZ REMARK 470 GLU C 212 CG CD OE1 OE2 REMARK 470 LYS E 232 CG CD CE NZ REMARK 470 GLU E 234 CG CD OE1 OE2 REMARK 470 GLU E 236 CG CD OE1 OE2 REMARK 470 THR P 61 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 186 -160.24 -167.49 REMARK 500 VAL A 234 -74.42 89.40 REMARK 500 VAL A 280 168.10 80.94 REMARK 500 LEU A 287 78.61 -118.20 REMARK 500 PRO A 288 49.26 -79.83 REMARK 500 ARG A 319 53.70 39.75 REMARK 500 GLU A 332 -5.63 66.87 REMARK 500 ASN A 340 -157.98 -96.59 REMARK 500 LEU A 348 -127.85 -109.93 REMARK 500 LEU A 351 -133.36 -126.60 REMARK 500 PRO A 404 14.69 -68.55 REMARK 500 SER A 419 13.60 -65.31 REMARK 500 LYS A 421 78.22 -169.65 REMARK 500 ARG B 30 -111.74 45.78 REMARK 500 THR B 69 -38.95 -137.65 REMARK 500 ALA B 84 -176.99 -171.33 REMARK 500 ASP B 94 98.23 84.76 REMARK 500 TYR D 107 -14.64 86.60 REMARK 500 MET D 109 104.45 56.11 REMARK 500 ASN D 110 28.62 86.01 REMARK 500 SER E 145 -153.17 -166.72 REMARK 500 LYS E 147 -49.98 118.89 REMARK 500 SER E 174 27.90 45.27 REMARK 500 LYS E 232 -89.78 -85.47 REMARK 500 GLU E 234 -43.87 90.12 REMARK 500 PHE E 235 -94.48 -9.67 REMARK 500 LEU P 74 66.48 -118.87 REMARK 500 HIS P 116 -102.95 -85.52 REMARK 500 HIS P 139 -5.59 83.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 244 ALA A 245 -35.37 REMARK 500 GLY B 93 ASP B 94 -148.73 REMARK 500 TYR D 107 GLY D 108 -37.24 REMARK 500 TRP D 121 GLY D 122 42.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1423 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA A 330 O REMARK 620 2 VAL A 333 O 78.6 REMARK 620 3 THR A 335 OG1 91.7 80.6 REMARK 620 4 ASP A 360 OD2 169.2 95.7 78.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1423 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W2N RELATED DB: PDB REMARK 900 WT PCSK9-DELTAC BOUND TO EGF-A H306Y MUTANT OF LDLR REMARK 900 RELATED ID: 2W2P RELATED DB: PDB REMARK 900 PCSK9-DELTAC D374A MUTANT BOUND TO WT EGF -A OF LDLR REMARK 900 RELATED ID: 2W2M RELATED DB: PDB REMARK 900 WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR REMARK 900 RELATED ID: 2W2O RELATED DB: PDB REMARK 900 PCSK9-DELTAC D374Y MUTANT BOUND TO WT EGF -A OF LDLR REMARK 900 RELATED ID: 2W2Q RELATED DB: PDB REMARK 900 PCSK9-DELTAC D374H MUTANT BOUND TO WT EGF -A OF LDLR REMARK 999 REMARK 999 SEQUENCE REMARK 999 LEUCINE PRESENT AT A417 IN ORIGINAL CONSTRUCT. POSSIBLE REMARK 999 NATURAL VARIANT DBREF 2XTJ A 153 451 UNP Q8NBP7 PCSK9_HUMAN 153 451 DBREF 2XTJ B 1 107 PDB 2XTJ 2XTJ 1 107 DBREF 2XTJ C 108 213 PDB 2XTJ 2XTJ 108 213 DBREF 2XTJ D 1 131 PDB 2XTJ 2XTJ 1 131 DBREF 2XTJ E 132 233 PDB 2XTJ 2XTJ 132 233 DBREF 2XTJ P 53 152 UNP Q8NBP7 PCSK9_HUMAN 53 152 SEQADV 2XTJ LEU A 417 UNP Q8NBP7 HIS 417 SEE REMARK 999 SEQADV 2XTJ ALA A 452 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ GLY A 453 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ THR A 454 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ ALA A 455 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ ALA A 456 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ ALA A 457 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ SER A 458 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 459 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 460 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 461 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 462 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 463 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ HIS A 464 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ MET P 39 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ LYS P 40 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ GLY P 41 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ SER P 42 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ LYS P 43 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ GLY P 44 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ SER P 45 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ LYS P 46 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ GLY P 47 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ SER P 48 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ LYS P 49 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ PRO P 50 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ MET P 51 UNP Q8NBP7 EXPRESSION TAG SEQADV 2XTJ SER P 52 UNP Q8NBP7 EXPRESSION TAG SEQRES 1 A 312 SER ILE PRO TRP ASN LEU GLU ARG ILE THR PRO PRO ARG SEQRES 2 A 312 TYR ARG ALA ASP GLU TYR GLN PRO PRO ASP GLY GLY SER SEQRES 3 A 312 LEU VAL GLU VAL TYR LEU LEU ASP THR SER ILE GLN SER SEQRES 4 A 312 ASP HIS ARG GLU ILE GLU GLY ARG VAL MET VAL THR ASP SEQRES 5 A 312 PHE GLU ASN VAL PRO GLU GLU ASP GLY THR ARG PHE HIS SEQRES 6 A 312 ARG GLN ALA SER LYS CYS ASP SER HIS GLY THR HIS LEU SEQRES 7 A 312 ALA GLY VAL VAL SER GLY ARG ASP ALA GLY VAL ALA LYS SEQRES 8 A 312 GLY ALA SER MET ARG SER LEU ARG VAL LEU ASN CYS GLN SEQRES 9 A 312 GLY LYS GLY THR VAL SER GLY THR LEU ILE GLY LEU GLU SEQRES 10 A 312 PHE ILE ARG LYS SER GLN LEU VAL GLN PRO VAL GLY PRO SEQRES 11 A 312 LEU VAL VAL LEU LEU PRO LEU ALA GLY GLY TYR SER ARG SEQRES 12 A 312 VAL LEU ASN ALA ALA CYS GLN ARG LEU ALA ARG ALA GLY SEQRES 13 A 312 VAL VAL LEU VAL THR ALA ALA GLY ASN PHE ARG ASP ASP SEQRES 14 A 312 ALA CYS LEU TYR SER PRO ALA SER ALA PRO GLU VAL ILE SEQRES 15 A 312 THR VAL GLY ALA THR ASN ALA GLN ASP GLN PRO VAL THR SEQRES 16 A 312 LEU GLY THR LEU GLY THR ASN PHE GLY ARG CYS VAL ASP SEQRES 17 A 312 LEU PHE ALA PRO GLY GLU ASP ILE ILE GLY ALA SER SER SEQRES 18 A 312 ASP CYS SER THR CYS PHE VAL SER GLN SER GLY THR SER SEQRES 19 A 312 GLN ALA ALA ALA HIS VAL ALA GLY ILE ALA ALA MET MET SEQRES 20 A 312 LEU SER ALA GLU PRO GLU LEU THR LEU ALA GLU LEU ARG SEQRES 21 A 312 GLN ARG LEU ILE LEU PHE SER ALA LYS ASP VAL ILE ASN SEQRES 22 A 312 GLU ALA TRP PHE PRO GLU ASP GLN ARG VAL LEU THR PRO SEQRES 23 A 312 ASN LEU VAL ALA ALA LEU PRO PRO SER THR HIS GLY ALA SEQRES 24 A 312 ALA GLY THR ALA ALA ALA SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 107 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 B 107 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 B 107 GLN GLY ILE ARG SER ALA LEU ASN TRP TYR GLN GLN LYS SEQRES 4 B 107 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ASN GLY SER SEQRES 5 B 107 THR LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 107 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 B 107 GLN PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN PHE SEQRES 8 B 107 ASP GLY ASP PRO THR PHE GLY GLN GLY THR LYS VAL GLU SEQRES 9 B 107 ILE LYS ARG SEQRES 1 C 106 THR VAL ALA ALA PRO SER VAL PHE ILE PHE PRO PRO SER SEQRES 2 C 106 ASP GLU GLN LEU LYS SER GLY THR ALA SER VAL VAL CYS SEQRES 3 C 106 LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA LYS VAL GLN SEQRES 4 C 106 TRP LYS VAL ASP ASN ALA LEU GLN SER GLY ASN SER GLN SEQRES 5 C 106 GLU SER VAL THR GLU GLN ASP SER LYS ASP SER THR TYR SEQRES 6 C 106 SER LEU SER SER THR LEU THR LEU SER LYS ALA ASP TYR SEQRES 7 C 106 GLU LYS HIS LYS VAL TYR ALA CYS GLU VAL THR HIS GLN SEQRES 8 C 106 GLY LEU SER SER PRO VAL THR LYS SER PHE ASN ARG GLY SEQRES 9 C 106 GLU ALA SEQRES 1 D 131 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 D 131 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 D 131 GLY THR PHE ASN SER HIS ALA ILE SER TRP VAL ARG GLN SEQRES 4 D 131 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY GLY ILE ASN SEQRES 5 D 131 PRO ILE LEU GLY ILE ALA ASN TYR ALA GLN LYS PHE GLN SEQRES 6 D 131 GLY ARG VAL THR ILE THR ALA ASP GLU SER THR SER THR SEQRES 7 D 131 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 D 131 ALA VAL TYR TYR CYS ALA ARG HIS TYR GLU ILE GLN ILE SEQRES 9 D 131 GLY ARG TYR GLY MET ASN VAL TYR TYR LEU MET TYR ARG SEQRES 10 D 131 PHE ALA SER TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 11 D 131 SER SEQRES 1 E 124 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 2 E 124 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 3 E 124 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 4 E 124 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 5 E 124 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 6 E 124 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 7 E 124 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 8 E 124 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER GLU PHE SEQRES 9 E 124 GLU GLN LYS LEU ILE SER GLU GLU ASP LEU ASN GLY ALA SEQRES 10 E 124 PRO HIS HIS HIS HIS HIS HIS SEQRES 1 P 114 MET LYS GLY SER LYS GLY SER LYS GLY SER LYS PRO MET SEQRES 2 P 114 SER ALA GLU ALA PRO GLU HIS GLY THR THR ALA THR PHE SEQRES 3 P 114 HIS ARG CYS ALA LYS ASP PRO TRP ARG LEU PRO GLY THR SEQRES 4 P 114 TYR VAL VAL VAL LEU LYS GLU GLU THR HIS LEU SER GLN SEQRES 5 P 114 SER GLU ARG THR ALA ARG ARG LEU GLN ALA GLN ALA ALA SEQRES 6 P 114 ARG ARG GLY TYR LEU THR LYS ILE LEU HIS VAL PHE HIS SEQRES 7 P 114 GLY LEU LEU PRO GLY PHE LEU VAL LYS MET SER GLY ASP SEQRES 8 P 114 LEU LEU GLU LEU ALA LEU LYS LEU PRO HIS VAL ASP TYR SEQRES 9 P 114 ILE GLU GLU ASP SER SER VAL PHE ALA GLN HET CA A1423 1 HETNAM CA CALCIUM ION FORMUL 7 CA CA 2+ FORMUL 8 HOH *199(H2 O) HELIX 1 1 ASP A 224 GLY A 236 1 13 HELIX 2 2 VAL A 261 GLN A 278 1 18 HELIX 3 3 SER A 294 ALA A 307 1 14 HELIX 4 4 GLY A 384 GLU A 403 1 20 HELIX 5 5 THR A 407 SER A 419 1 13 HELIX 6 6 GLN B 79 PHE B 83 5 5 HELIX 7 7 SER C 120 GLY C 127 1 8 HELIX 8 8 LYS C 182 GLU C 186 1 5 HELIX 9 9 GLN D 62 GLN D 65 5 4 HELIX 10 10 ARG D 87 THR D 91 5 5 HELIX 11 11 SER E 174 ALA E 176 5 3 HELIX 12 12 SER E 205 LEU E 207 5 3 HELIX 13 13 LYS E 219 ASN E 222 5 4 HELIX 14 14 LYS P 69 PRO P 71 5 3 HELIX 15 15 HIS P 87 ARG P 104 1 18 HELIX 16 16 SER P 127 ASP P 129 5 3 HELIX 17 17 LEU P 130 LEU P 135 1 6 SHEET 1 AA 7 VAL A 200 GLU A 206 0 SHEET 2 AA 7 MET A 247 ARG A 251 1 O MET A 247 N MET A 201 SHEET 3 AA 7 GLU A 181 ASP A 186 1 O VAL A 182 N ARG A 248 SHEET 4 AA 7 LEU A 283 LEU A 287 1 O VAL A 284 N TYR A 183 SHEET 5 AA 7 VAL A 310 ALA A 314 1 O VAL A 310 N VAL A 285 SHEET 6 AA 7 ILE A 334 THR A 339 1 O ILE A 334 N THR A 313 SHEET 7 AA 7 LEU A 361 PRO A 364 1 O LEU A 361 N GLY A 337 SHEET 1 AB 2 LYS A 258 THR A 260 0 SHEET 2 AB 2 VAL P 140 ALA P 151 -1 O VAL P 149 N GLY A 259 SHEET 1 AC 6 TYR A 325 SER A 326 0 SHEET 2 AC 6 LEU A 289 GLY A 292 -1 O GLY A 291 N SER A 326 SHEET 3 AC 6 VAL P 140 ALA P 151 -1 O PHE P 150 N ALA A 290 SHEET 4 AC 6 ARG P 73 LEU P 82 -1 N LEU P 74 O ASP P 146 SHEET 5 AC 6 GLY P 121 LYS P 125 -1 O PHE P 122 N VAL P 80 SHEET 6 AC 6 LYS P 110 PHE P 115 -1 O LYS P 110 N LYS P 125 SHEET 1 AD 4 TYR A 325 SER A 326 0 SHEET 2 AD 4 LEU A 289 GLY A 292 -1 O GLY A 291 N SER A 326 SHEET 3 AD 4 VAL P 140 ALA P 151 -1 O PHE P 150 N ALA A 290 SHEET 4 AD 4 THR P 63 HIS P 65 -1 O THR P 63 N ILE P 143 SHEET 1 AE 6 ILE A 368 ALA A 371 0 SHEET 2 AE 6 CYS A 378 GLN A 382 -1 O VAL A 380 N GLY A 370 SHEET 3 AE 6 VAL D 111 MET D 115 -1 O TYR D 112 N PHE A 379 SHEET 4 AE 6 ALA D 92 GLN D 103 -1 O TYR D 100 N MET D 115 SHEET 5 AE 6 THR D 125 VAL D 129 1 O THR D 125 N TYR D 94 SHEET 6 AE 6 GLU D 10 LYS D 12 -1 O GLU D 10 N THR D 128 SHEET 1 AF 7 ILE A 368 ALA A 371 0 SHEET 2 AF 7 CYS A 378 GLN A 382 -1 O VAL A 380 N GLY A 370 SHEET 3 AF 7 VAL D 111 MET D 115 -1 O TYR D 112 N PHE A 379 SHEET 4 AF 7 ALA D 92 GLN D 103 -1 O TYR D 100 N MET D 115 SHEET 5 AF 7 ALA D 33 GLN D 39 -1 O ALA D 33 N HIS D 99 SHEET 6 AF 7 GLU D 46 ASN D 52 -1 O GLU D 46 N ARG D 38 SHEET 7 AF 7 ILE D 57 TYR D 60 -1 O ILE D 57 N ASN D 52 SHEET 1 BA 4 MET B 4 SER B 7 0 SHEET 2 BA 4 VAL B 19 ALA B 25 -1 O THR B 22 N SER B 7 SHEET 3 BA 4 ASP B 70 ILE B 75 -1 O PHE B 71 N CYS B 23 SHEET 4 BA 4 PHE B 62 SER B 67 -1 O SER B 63 N THR B 74 SHEET 1 BB 4 SER B 10 ALA B 13 0 SHEET 2 BB 4 THR B 101 ILE B 105 1 O LYS B 102 N LEU B 11 SHEET 3 BB 4 VAL B 85 GLN B 90 -1 O TYR B 86 N THR B 101 SHEET 4 BB 4 THR B 96 PHE B 97 -1 O THR B 96 N GLN B 90 SHEET 1 BC 6 SER B 10 ALA B 13 0 SHEET 2 BC 6 THR B 101 ILE B 105 1 O LYS B 102 N LEU B 11 SHEET 3 BC 6 VAL B 85 GLN B 90 -1 O TYR B 86 N THR B 101 SHEET 4 BC 6 LEU B 33 GLN B 38 -1 O ASN B 34 N GLN B 89 SHEET 5 BC 6 LYS B 45 TYR B 49 -1 O LYS B 45 N GLN B 37 SHEET 6 BC 6 THR B 53 LEU B 54 -1 O THR B 53 N TYR B 49 SHEET 1 BD 2 THR B 96 PHE B 97 0 SHEET 2 BD 2 VAL B 85 GLN B 90 -1 O GLN B 90 N THR B 96 SHEET 1 CA 4 SER C 113 PHE C 117 0 SHEET 2 CA 4 THR C 128 PHE C 138 -1 O VAL C 132 N PHE C 117 SHEET 3 CA 4 TYR C 172 SER C 181 -1 O TYR C 172 N PHE C 138 SHEET 4 CA 4 SER C 158 VAL C 162 -1 O GLN C 159 N THR C 177 SHEET 1 CB 4 ALA C 152 GLN C 154 0 SHEET 2 CB 4 LYS C 144 VAL C 149 -1 O TRP C 147 N GLN C 154 SHEET 3 CB 4 VAL C 190 THR C 196 -1 O ALA C 192 N LYS C 148 SHEET 4 CB 4 VAL C 204 ASN C 209 -1 O VAL C 204 N VAL C 195 SHEET 1 DA 4 GLN D 3 GLN D 6 0 SHEET 2 DA 4 VAL D 18 SER D 25 -1 O LYS D 23 N VAL D 5 SHEET 3 DA 4 THR D 78 LEU D 83 -1 O ALA D 79 N CYS D 22 SHEET 4 DA 4 VAL D 68 ASP D 73 -1 O THR D 69 N GLU D 82 SHEET 1 EA 2 SER E 138 LEU E 142 0 SHEET 2 EA 2 THR E 153 TYR E 163 -1 O GLY E 157 N LEU E 142 SHEET 1 EB 2 THR E 149 SER E 150 0 SHEET 2 EB 2 THR E 153 TYR E 163 -1 O THR E 153 N SER E 150 SHEET 1 EC 2 VAL E 181 THR E 183 0 SHEET 2 EC 2 TYR E 194 PRO E 203 -1 O VAL E 199 N HIS E 182 SHEET 1 ED 2 VAL E 187 LEU E 188 0 SHEET 2 ED 2 TYR E 194 PRO E 203 1 O SER E 195 N VAL E 187 SHEET 1 EE 3 THR E 169 TRP E 172 0 SHEET 2 EE 3 ILE E 213 HIS E 218 -1 O ASN E 215 N SER E 171 SHEET 3 EE 3 THR E 223 LYS E 228 -1 O THR E 223 N HIS E 218 SSBOND 1 CYS A 223 CYS A 255 1555 1555 2.05 SSBOND 2 CYS A 323 CYS A 358 1555 1555 2.07 SSBOND 3 CYS A 375 CYS A 378 1555 1555 2.06 SSBOND 4 CYS B 23 CYS B 88 1555 1555 2.07 SSBOND 5 CYS C 133 CYS C 193 1555 1555 2.03 SSBOND 6 CYS D 22 CYS D 96 1555 1555 2.07 SSBOND 7 CYS E 158 CYS E 214 1555 1555 2.05 LINK O ALA A 330 CA CA A1423 1555 1555 2.71 LINK O VAL A 333 CA CA A1423 1555 1555 2.26 LINK OG1 THR A 335 CA CA A1423 1555 1555 2.91 LINK OD2 ASP A 360 CA CA A1423 1555 1555 2.32 CISPEP 1 PRO A 279 VAL A 280 0 -14.75 CISPEP 2 SER A 326 PRO A 327 0 1.10 CISPEP 3 SER B 7 PRO B 8 0 -9.41 CISPEP 4 ASP B 92 GLY B 93 0 27.54 CISPEP 5 TYR C 139 PRO C 140 0 1.23 CISPEP 6 GLY D 108 MET D 109 0 19.33 CISPEP 7 MET D 109 ASN D 110 0 9.24 CISPEP 8 SER E 146 LYS E 147 0 8.05 CISPEP 9 PHE E 164 PRO E 165 0 -8.94 CISPEP 10 GLU E 166 PRO E 167 0 -1.11 CISPEP 11 SER E 233 GLU E 234 0 20.24 SITE 1 AC1 4 ALA A 330 VAL A 333 THR A 335 ASP A 360 CRYST1 66.589 67.834 250.860 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015017 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014742 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003986 0.00000